Phyto Biotech Private Limited - Due diligence report

A 360° intelligence report on Phyto Biotech: trust score, financial health, credit view, compliance, directors, growth and distress signals …

2009-03-13 Kolkata, West Bengal Active Unlisted Active Compliant
Share
PB Phyto Biotech Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Phyto Biotech — 360° Intelligence Report

Generated from MCA filings & public records
63/100
Trust Score
Moderate

Phyto Biotech is assessed as Moderate with a Trust Score of 63/100. Phyto Biotech is an active private limited indian non-government company incorporated in 2009, operating in the Pharma sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and high financial risk profile.

Report generated on 17 Jul 2026 from the latest processed filings. Phyto Biotech Private Limited snapshot & full profile →

Financial Health › Weak
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Good

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
63/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
56/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
35/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
40/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
40/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
60/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 40/100 Caution Indicated
  • Liabilities ≈ 38% EBITDA - stretched.
  • No open charges - unencumbered balance sheet.
  • Elevated gearing (D/E 1.42).
  • Working-capital cover adequate.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 56/100 Moderate
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Flagged by authority: NCLT.
  • Litigation present in 2 court forum(s).
  • 4 active GST registration(s).
Legal cases on record (2)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
VIJAY MASKARA 01234567 Director 01/04/2018 6 yrs Approved
ARUN KUMAR MOHTA 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2021 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
17 allotment(s) · 2 transfer(s)

Promoters hold a minority stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 40 · Distress 60
Growth signals & trust indicators
Operating for 17+ years.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Losses deepening year-on-year.
Compliance score is weak (56/100).
2 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence59/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment42/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view44/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
26 Sep 2018
Director ceased
VIJAY MASKARA
14 May 2018
Director ceased
RAJSHREE MOHTA
20 Mar 2018
Director appointed
VIJAY MASKARA (Director)
Director ceased
KARAN KUMAR KAKKAD
29 Jun 2016
Securities allotted
150000 Equity Shares Without Differential Rights - 15.00 Lakh raised
31 Mar 2016
Securities allotted
150000 Equity Shares Without Differential Rights - 15.00 Lakh raised
Share transfer (FY 2016)
300000.00000000 shares to GARODIA AND BIJAY KUMAR
Share transfer (FY 2016)
200000.00000000 shares to AND SLA
30 Sep 2015
Securities allotted
200000 Equity Shares Without Differential Rights - 20.00 Lakh raised
Securities allotted
500000 Equity Shares Without Differential Rights - 50.00 Lakh raised
31 Mar 2015
Securities allotted
500000 Equity Shares Without Differential Rights - 50.00 Lakh raised
Securities allotted
200000 Equity Shares Without Differential Rights - 20.00 Lakh raised
23 Feb 2015
Securities allotted
500000 Equity Shares Without Differential Rights - 50.00 Lakh raised
10

Key Observations

Auto-generated from the data above
Revenue declined 2.1x over the last 4 financial year(s).
Net profit margin moved from 24% to 0.86.
Debt-to-equity stands at 61% - leverage worth monitoring.
Net worth is positive.
2 active director(s) / partner(s); board looks stable and experienced.
4 active GST registration(s) indicate ongoing business operations.
Promoters hold a minority stake as per the FY 2021 annual return.
Capital has been raised through 17 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Safewomen Healthcare Private Limited U85310TG2019PTC129561 Hyderabad, Telangana, India
Trans Vitals Private Limited U29100PN2020PTC190421 Pune, Maharashtra, India
Bionova Tech Private Limited U73100OR2008PTC010449 Baleshwar Sadar, Orissa, India
Kvayat Medical U33309TG2018PTC125627 Rajendra Nagar, Hyderabad, Telangana, India
Craste U74999MP2018PTC046510 Gwalior, Madhya Pradesh, India
Waste Chakra U90000TN2019PTC128592 Chennai, Tamil Nadu, India
Ish Facilities Management Private Limited U73200RJ2011PTC034261 Jaipur, Rajasthan, India
Pinglaksh Anveshnam Private Limited U36996HR2018PTC073960 Gurgaon, Haryana, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Phyto Biotech before audits and certifications: compliance score 56/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Phyto Biotech: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 40/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score 40/100, margin trends, ownership structure and peer set for Phyto Biotech - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 63/100, distress signals and MSME payment-delay disclosures - know whether Phyto Biotech pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Phyto Biotech - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Phyto Biotech an active company?

Phyto Biotech has MCA status “Active” with a compliance score of 56/100 (Moderate).

Is Phyto Biotech financially healthy?

Phyto Biotech has a Financial Health Score of 35/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Phyto Biotech?

Its overall Trust Score is 63/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Phyto Biotech?

Promoters hold a minority stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Phyto Biotech have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Phyto Biotech up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 56/100 (Moderate).

Is it risky to lend to Phyto Biotech?

Its Credit Risk Score is 40/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.